Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 134 Pages
Report ld: 6924498
Request Sample
Customized Report
Hydroxychloroquine Sulfate Market Size(US$)

CAGR 2026-2032
1.9%
Market Size,2032
USD 1,054
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hydroxychloroquine Sulfate was estimated to be worth US$ 928 million in 2025 and is projected to reach US$ 1054 million, growing at a CAGR of 1.9% from 2026 to 2032.
The North American market for Hydroxychloroquine Sulfate was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Hydroxychloroquine Sulfate was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Hydroxychloroquine Sulfate was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Hydroxychloroquine Sulfate market include Sandoz, TEVA, Mylan, HIKMA, IPCA, Jiangsu Shenhua Pharmaceutical, Sanofi, TAJ Pharma, Shanghai Zhongxisanwei, Wuhan Wuyao Pharmaceutical, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Hydroxychloroquine Sulfate, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Hydroxychloroquine Sulfate market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Hydroxychloroquine Sulfate.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Hydroxychloroquine Sulfate manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Hydroxychloroquine Sulfate sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Hydroxychloroquine Sulfate sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hydroxychloroquine Sulfate Product Introduction
1.2 Global Hydroxychloroquine Sulfate Market Size Forecast
1.2.1 Global Hydroxychloroquine Sulfate Sales Value (2021–2032)
1.2.2 Global Hydroxychloroquine Sulfate Sales Volume (2021–2032)
1.2.3 Global Hydroxychloroquine Sulfate Sales Price (2021–2032)
1.3 Hydroxychloroquine Sulfate Market Trends & Drivers
1.3.1 Hydroxychloroquine Sulfate Industry Trends
1.3.2 Hydroxychloroquine Sulfate Market Drivers & Opportunities
1.3.3 Hydroxychloroquine Sulfate Market Challenges
1.3.4 Hydroxychloroquine Sulfate Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hydroxychloroquine Sulfate Players Revenue Ranking (2025)
2.2 Global Hydroxychloroquine Sulfate Revenue by Company (2021–2026)
2.3 Global Hydroxychloroquine Sulfate Sales Volume Ranking of Players (2025)
2.4 Global Hydroxychloroquine Sulfate Sales Volume by Company (2021–2026)
2.5 Global Hydroxychloroquine Sulfate Average Price by Company (2021–2026)
2.6 Key Manufacturers Hydroxychloroquine Sulfate Manufacturing Base and Headquarters
2.7 Key Manufacturers Hydroxychloroquine Sulfate Product Offerings
2.8 Key Manufacturers Start of Mass Production of Hydroxychloroquine Sulfate
2.9 Hydroxychloroquine Sulfate Market Competitive Analysis
2.9.1 Hydroxychloroquine Sulfate Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Hydroxychloroquine Sulfate Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hydroxychloroquine Sulfate revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Hydroxychloroquine Sulfate Market Classification
3.1 Introduction by Type
3.1.1 USP Standards Grade
3.1.2 EP Standards Grade
3.1.3 Pharmaceutical Standards Grade
3.1.4 Others
3.1.5 Global Hydroxychloroquine Sulfate Sales Value by Type
3.1.5.1 Global Hydroxychloroquine Sulfate Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Hydroxychloroquine Sulfate Sales Value, by Type (2021–2032)
3.1.5.3 Global Hydroxychloroquine Sulfate Sales Value, by Type (%), 2021–2032
3.1.6 Global Hydroxychloroquine Sulfate Sales Volume by Type
3.1.6.1 Global Hydroxychloroquine Sulfate Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Hydroxychloroquine Sulfate Sales Volume, by Type (2021–2032)
3.1.6.3 Global Hydroxychloroquine Sulfate Sales Volume, by Type (%), 2021–2032
3.1.7 Global Hydroxychloroquine Sulfate Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Rheumatoid Joint
4.1.2 Adolescent Chronic Joint
4.1.3 Discoid and Systemic Lupus Erythemato Sus
4.1.4 Skin Lesions
4.2 Global Hydroxychloroquine Sulfate Sales Value by Application
4.2.1 Global Hydroxychloroquine Sulfate Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Hydroxychloroquine Sulfate Sales Value, by Application (2021–2032)
4.2.3 Global Hydroxychloroquine Sulfate Sales Value, by Application (%), 2021–2032
4.3 Global Hydroxychloroquine Sulfate Sales Volume by Application
4.3.1 Global Hydroxychloroquine Sulfate Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Hydroxychloroquine Sulfate Sales Volume, by Application (2021–2032)
4.3.3 Global Hydroxychloroquine Sulfate Sales Volume, by Application (%), 2021–2032
4.4 Global Hydroxychloroquine Sulfate Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Hydroxychloroquine Sulfate Sales Value by Region
5.1.1 Global Hydroxychloroquine Sulfate Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Hydroxychloroquine Sulfate Sales Value by Region (2021–2026)
5.1.3 Global Hydroxychloroquine Sulfate Sales Value by Region (2027–2032)
5.1.4 Global Hydroxychloroquine Sulfate Sales Value by Region (%), 2021–2032
5.2 Global Hydroxychloroquine Sulfate Sales Volume by Region
5.2.1 Global Hydroxychloroquine Sulfate Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Hydroxychloroquine Sulfate Sales Volume by Region (2021–2026)
5.2.3 Global Hydroxychloroquine Sulfate Sales Volume by Region (2027–2032)
5.2.4 Global Hydroxychloroquine Sulfate Sales Volume by Region (%), 2021–2032
5.3 Global Hydroxychloroquine Sulfate Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Hydroxychloroquine Sulfate Sales Value, 2021–2032
5.4.2 North America Hydroxychloroquine Sulfate Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Hydroxychloroquine Sulfate Sales Value, 2021–2032
5.5.2 Europe Hydroxychloroquine Sulfate Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Hydroxychloroquine Sulfate Sales Value, 2021–2032
5.6.2 Asia Pacific Hydroxychloroquine Sulfate Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Hydroxychloroquine Sulfate Sales Value, 2021–2032
5.7.2 South America Hydroxychloroquine Sulfate Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hydroxychloroquine Sulfate Sales Value, 2021–2032
5.8.2 Middle East & Africa Hydroxychloroquine Sulfate Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hydroxychloroquine Sulfate Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Hydroxychloroquine Sulfate Sales Value and Sales Volume
6.2.1 Key Countries/Regions Hydroxychloroquine Sulfate Sales Value, 2021–2032
6.2.2 Key Countries/Regions Hydroxychloroquine Sulfate Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Hydroxychloroquine Sulfate Sales Value, 2021–2032
6.3.2 United States Hydroxychloroquine Sulfate Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Hydroxychloroquine Sulfate Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Hydroxychloroquine Sulfate Sales Value, 2021–2032
6.4.2 Europe Hydroxychloroquine Sulfate Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Hydroxychloroquine Sulfate Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Hydroxychloroquine Sulfate Sales Value, 2021–2032
6.5.2 China Hydroxychloroquine Sulfate Sales Value by Type (%), 2025 vs 2032
6.5.3 China Hydroxychloroquine Sulfate Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Hydroxychloroquine Sulfate Sales Value, 2021–2032
6.6.2 Japan Hydroxychloroquine Sulfate Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Hydroxychloroquine Sulfate Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Hydroxychloroquine Sulfate Sales Value, 2021–2032
6.7.2 South Korea Hydroxychloroquine Sulfate Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Hydroxychloroquine Sulfate Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Hydroxychloroquine Sulfate Sales Value, 2021–2032
6.8.2 Southeast Asia Hydroxychloroquine Sulfate Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Hydroxychloroquine Sulfate Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Hydroxychloroquine Sulfate Sales Value, 2021–2032
6.9.2 India Hydroxychloroquine Sulfate Sales Value by Type (%), 2025 vs 2032
6.9.3 India Hydroxychloroquine Sulfate Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Sandoz
7.1.1 Sandoz Company Information
7.1.2 Sandoz Introduction and Business Overview
7.1.3 Sandoz Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Sandoz Hydroxychloroquine Sulfate Product Offerings
7.1.5 Sandoz Recent Developments
7.2 TEVA
7.2.1 TEVA Company Information
7.2.2 TEVA Introduction and Business Overview
7.2.3 TEVA Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 TEVA Hydroxychloroquine Sulfate Product Offerings
7.2.5 TEVA Recent Developments
7.3 Mylan
7.3.1 Mylan Company Information
7.3.2 Mylan Introduction and Business Overview
7.3.3 Mylan Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Mylan Hydroxychloroquine Sulfate Product Offerings
7.3.5 Mylan Recent Developments
7.4 HIKMA
7.4.1 HIKMA Company Information
7.4.2 HIKMA Introduction and Business Overview
7.4.3 HIKMA Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 HIKMA Hydroxychloroquine Sulfate Product Offerings
7.4.5 HIKMA Recent Developments
7.5 IPCA
7.5.1 IPCA Company Information
7.5.2 IPCA Introduction and Business Overview
7.5.3 IPCA Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 IPCA Hydroxychloroquine Sulfate Product Offerings
7.5.5 IPCA Recent Developments
7.6 Jiangsu Shenhua Pharmaceutical
7.6.1 Jiangsu Shenhua Pharmaceutical Company Information
7.6.2 Jiangsu Shenhua Pharmaceutical Introduction and Business Overview
7.6.3 Jiangsu Shenhua Pharmaceutical Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Jiangsu Shenhua Pharmaceutical Hydroxychloroquine Sulfate Product Offerings
7.6.5 Jiangsu Shenhua Pharmaceutical Recent Developments
7.7 Sanofi
7.7.1 Sanofi Company Information
7.7.2 Sanofi Introduction and Business Overview
7.7.3 Sanofi Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Sanofi Hydroxychloroquine Sulfate Product Offerings
7.7.5 Sanofi Recent Developments
7.8 TAJ Pharma
7.8.1 TAJ Pharma Company Information
7.8.2 TAJ Pharma Introduction and Business Overview
7.8.3 TAJ Pharma Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 TAJ Pharma Hydroxychloroquine Sulfate Product Offerings
7.8.5 TAJ Pharma Recent Developments
7.9 Shanghai Zhongxisanwei
7.9.1 Shanghai Zhongxisanwei Company Information
7.9.2 Shanghai Zhongxisanwei Introduction and Business Overview
7.9.3 Shanghai Zhongxisanwei Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Shanghai Zhongxisanwei Hydroxychloroquine Sulfate Product Offerings
7.9.5 Shanghai Zhongxisanwei Recent Developments
7.10 Wuhan Wuyao Pharmaceutical
7.10.1 Wuhan Wuyao Pharmaceutical Company Information
7.10.2 Wuhan Wuyao Pharmaceutical Introduction and Business Overview
7.10.3 Wuhan Wuyao Pharmaceutical Hydroxychloroquine Sulfate Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Wuhan Wuyao Pharmaceutical Hydroxychloroquine Sulfate Product Offerings
7.10.5 Wuhan Wuyao Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Hydroxychloroquine Sulfate Industrial Chain
8.2 Hydroxychloroquine Sulfate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Hydroxychloroquine Sulfate Sales Model
8.5.2 Sales Channels
8.5.3 Hydroxychloroquine Sulfate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hydroxychloroquine Sulfate market was valued at US$ 928 million in 2025 and is anticipated to reach US$ 1054 million by 2032, at a CAGR of 1.9% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 135
USD 2900.00
(Single User License)
The global Hydroxychloroquine Sulfate market is projected to grow from US$ 913 million in 2024 to US$ 1036 million by 2031, at a CAGR of 1.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 132
USD 4900.00
(Single User License)
The global Hydroxychloroquine Sulfate market size was US$ 913 million in 2024 and is forecast to a readjusted size of US$ 1036 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 80
USD 4250.00
(Single User License)
The global market for Hydroxychloroquine Sulfate was estimated to be worth US$ 913 million in 2024 and is forecast to a readjusted size of US$ 1036 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 103
USD 3950.00
(Single User License)
The global market for Hydroxychloroquine Sulfate was valued at US$ 913 million in the year 2024 and is projected to reach a revised size of US$ 1036 million by 2031, growing at a CAGR of 1.9% during the forecast period.
Published Date: 2025-02-24
Pages: 88
USD 2900.00
(Single User License)
The global Hydroxychloroquine Sulfate market was valued at US$ 879.4 million in 2023 and is anticipated to reach US$ 1002.5 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
Published Date: 2024-01-31
Pages: 103
USD 2900.00
(Single User License)
The global market for Hydroxychloroquine Sulfate was estimated to be worth US$ 879.4 million in 2023 and is forecast to a readjusted size of US$ 1002.5 million by 2030 with a CAGR of 1.9% during the forecast period 2024-2030
Published Date: 2024-01-16
Pages: 125
USD 3950.00
(Single User License)
The global Hydroxychloroquine Sulfate market was valued at US$ 928 million in 2025 and is anticipated to reach US$ 1054 million by 2032, at a CAGR of 1.9% from 2026 to 2032.
Published: 2026-04-27
Pages: 135
The global Hydroxychloroquine Sulfate market is projected to grow from US$ 913 million in 2024 to US$ 1036 million by 2031, at a CAGR of 1.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 132
The global Hydroxychloroquine Sulfate market size was US$ 913 million in 2024 and is forecast to a readjusted size of US$ 1036 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 80
The global market for Hydroxychloroquine Sulfate was estimated to be worth US$ 913 million in 2024 and is forecast to a readjusted size of US$ 1036 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 103
The global market for Hydroxychloroquine Sulfate was valued at US$ 913 million in the year 2024 and is projected to reach a revised size of US$ 1036 million by 2031, growing at a CAGR of 1.9% during the forecast period.
Published: 2025-02-24
Pages: 88
The global Hydroxychloroquine Sulfate market was valued at US$ 879.4 million in 2023 and is anticipated to reach US$ 1002.5 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
Published: 2024-01-31
Pages: 103
The global market for Hydroxychloroquine Sulfate was estimated to be worth US$ 879.4 million in 2023 and is forecast to a readjusted size of US$ 1002.5 million by 2030 with a CAGR of 1.9% during the forecast period 2024-2030
Published: 2024-01-16
Pages: 125
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now